12/3
08:44 am
aplt
Applied Therapeutics (NASDAQ:APLT) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $1.00 price target on the stock.
Low
Report
Applied Therapeutics (NASDAQ:APLT) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $1.00 price target on the stock.
11/26
02:02 pm
aplt
Applied Therapeutics (NASDAQ:APLT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Applied Therapeutics (NASDAQ:APLT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/20
07:50 am
aplt
Applied Therapeutics Announces Corporate Updates [Yahoo! Finance]
Low
Report
Applied Therapeutics Announces Corporate Updates [Yahoo! Finance]
11/20
07:00 am
aplt
Applied Therapeutics Announces Corporate Updates
Low
Report
Applied Therapeutics Announces Corporate Updates
11/14
07:41 pm
aplt
Can Changes in Leadership and FDA Dialogue Reshape Applied Therapeutics' (APLT) Path in Rare Diseases? [Yahoo! Finance]
High
Report
Can Changes in Leadership and FDA Dialogue Reshape Applied Therapeutics' (APLT) Path in Rare Diseases? [Yahoo! Finance]
11/13
07:40 am
aplt
Applied Therapeutics GAAP EPS of -$0.13 beats by $0.03 [Seeking Alpha]
High
Report
Applied Therapeutics GAAP EPS of -$0.13 beats by $0.03 [Seeking Alpha]
11/13
07:00 am
aplt
Applied Therapeutics Reports Third Quarter 2025 Financial Results
High
Report
Applied Therapeutics Reports Third Quarter 2025 Financial Results
10/28
10:25 am
aplt
Halper Sadeh LLC Encourages Applied Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Medium
Report
Halper Sadeh LLC Encourages Applied Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
10/5
05:18 am
aplt
Institutional investors may adopt severe steps after Applied Therapeutics, Inc.'s (NASDAQ:APLT) latest 19% drop adds to a year losses [Yahoo! Finance]
Medium
Report
Institutional investors may adopt severe steps after Applied Therapeutics, Inc.'s (NASDAQ:APLT) latest 19% drop adds to a year losses [Yahoo! Finance]
9/12
08:38 am
aplt
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); LuxUrban Hotels Inc. (OTC: LUXH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims o
Medium
Report
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); LuxUrban Hotels Inc. (OTC: LUXH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims o
9/11
08:14 am
aplt
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Lantheus Holdings, Inc. (NASDAQ: LNTH); Savara Inc. (NASDAQ: SVRA); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your
Low
Report
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Lantheus Holdings, Inc. (NASDAQ: LNTH); Savara Inc. (NASDAQ: SVRA); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your
9/10
09:38 am
aplt
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf
Low
Report
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf